Streetbeat News

Analyst Ratings

BNOX

Bionomics Limited (NASDAQ:BNOX) announced positive results from its Phase 2b ATTUNE trial of BNC210 for post-traumatic stress disorder (PTSD). The trial met its primary endpoint, leading to an upgrade of the stock from Neutral to Buy by HC Wainwright with a price target of $8. The company is now focusing on discussions with the FDA for the next phases of the PTSD program. Despite concerns about potential liver issues, the absence of observed liver injury is reassuring.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 6:22 pm

ADI

UBER

Uber Technologies, Inc. (UBER) shares are trading higher after the company announced a CFO transition. Prashanth Mahendra-Rajah, currently CFO of Analog Devices (ADI), will join Uber as CFO on November 13. Uber's CEO, Dara Khosrowshahi, expressed confidence in Prashanth's ability to deliver innovation and efficiency.

Portfolio Pulse from Ryan Gustafson

September 28, 2023 | 6:21 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, expressed optimism about the company's growth in key US markets for 2024 and 2025. The statement was made during a Benzinga Cannabis Capital Conference.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:20 pm

GOOGL

A significant bearish stance has been taken on Alphabet (NASDAQ:GOOGL) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 42% bullish and 57% bearish. The whales have been targeting a price range from $50.0 to $160.0 for Alphabet over the last 3 months. Alphabet's current price is up 1.36% at $132.31. Several experts have given their ratings on Alphabet, with price targets ranging from $138 to $150.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:19 pm

VSTM

Verastem Oncology (NASDAQ:VSTM) has presented updates on its avutometinib and defactinib programs at the 5th Annual RAS-Targeted Drug Development Summit. The updates include clinical trial results showing an overall response rate of 42% in patients with low grade serous ovarian cancer. The company's FRAME study, which evaluates the combination of avutometinib and defactinib in patients with advanced solid tumors, continues to provide proof-of-concept supporting Breakthrough Therapy Designation for the combination.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:16 pm

NEP

NextEra Energy Partners LP (NEP) shares have fallen over 15% following several analyst downgrades after the company revised its limited partner distribution per unit growth rate. NEP now expects a growth rate of 5% to 8% annually through at least 2026. Analysts from Oppenheimer, Raymond James, and JP Morgan have downgraded the stock and lowered their price targets. NEP views the event as a reaction to the current capital markets environment.

Portfolio Pulse from Lekha Gupta

September 28, 2023 | 6:09 pm

TSLA

Tesla Inc's shares are trading higher by 2.1% amid ongoing UAW strikes at the company's Big 3 rivals. Morgan Stanley maintained an Overweight rating and $400 on the stock. The strikes at Tesla's rivals can disrupt their production and supply chains, potentially giving Tesla a competitive advantage. The company might see opportunities to expand its production and sales during this period.

Portfolio Pulse from Henry Khederian

September 28, 2023 | 6:04 pm

AIG

American Intl Gr's (NYSE:AIG) short percent of float has risen 5.38% since its last report, with 6.25 million shares sold short, which is 0.98% of all regular shares available for trading. It would take traders 2.02 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, AIG's short interest as a percentage of float is less than its peer group average of 1.66%.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:00 pm

NEE

NextEra Energy's (NYSE:NEE) short percent of float has fallen 24.79% since its last report, with 18.34 million shares sold short, which is 0.91% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Compared to its peers, NextEra Energy has less short interest.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:00 pm

MO

Altria Group's (NYSE:MO) short percent of float has risen 6.49% since its last report, with 14.48 million shares sold short, which is 0.82% of all regular shares available for trading. This increase in short interest can signal that investors have become more bearish. However, Altria Group's peer group average for short interest as a percentage of float is 2.30%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:00 pm